Correction to: British Journal of Cancer (2011) 104, 948–956; doi:10.1038/bjc.2011.54
When published originally, earlier this year in Volume 104, the authors noticed a couple of errors in the Results section.
The first is in the subheading entitled ‘Selection of peptide- and ET-specific T cells’. In the second paragraph of this subsection, on page 951, the second sentence should read ‘For example, of the T cells initially specifically selected with the CHM1319/HLA-A*0201-multimer, 96 cell lines were grown and tested for specific IFN-γ release against CHM1319 peptide.’
The legend of Figure 4 should read ‘Low granzyme B responses against HLA class I blocked A673 and HLA-A*0201+ PBMC compared with unblocked A673.’
The publishers and authors are now happy to correct these errors.
Change history
29 March 2012
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/bjc.2011.54
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Thiel, U., Pirson, S., Müller-Spahn, C. et al. Erratum: Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells. Br J Cancer 105, 596 (2011). https://doi.org/10.1038/bjc.2011.305
Published:
Issue Date:
DOI: https://doi.org/10.1038/bjc.2011.305